11:14 AM
 | 
Jul 13, 2018
 |  BC Extra  |  Financial News

Follow-on roundup: Myovant, CytomX, Spero

Myovant Sciences Ltd. (NYSE:MYOV), CytomX Therapeutics Inc. (NASDAQ:CTMX) and Spero Therapeutics Inc. (NASDAQ:SPRO) each priced follow-ons late Thursday, raising a total of $275 million.

Myovant raised $75 million through the sale of 3.3 million shares at $22.50 in a follow-on underwritten by J.P. Morgan, Goldman Sachs, Barclays, JMP Securities and Baird. The price is a 7% discount to its close of $24.10 on Wednesday, when it proposed the follow-on after trading hours. Myovant shed 4%...

Read the full 353 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >